Skip to main content
logo
StageZero Life Sciences Ltd. (SZLSF)
OTCMKTS · Delayed Price · Currency is USD
0.0240
0.00 (0.00%)
Jun 25, 2025, 1:19 PM EDT

StageZero Life Sciences Revenue

StageZero Life Sciences had revenue of $499.66K in the quarter ending September 30, 2024, a decrease of -37.02%. This brings the company's revenue in the last twelve months to $2.88M, down -37.63% year-over-year. In the year 2022, StageZero Life Sciences had annual revenue of $3.80M, down -25.12%.

Revenue (ttm)
2.88M
Revenue Growth
-37.63%
P/S Ratio
1.26
Revenue / Employee
72.06K
Employees
40
Market Cap
3.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20223.80M-1.27M-25.12%
Dec 31, 20215.07M916.35K22.07%
Dec 31, 20204.15M4.01M2,893.29%
Dec 31, 2019138.70K-47.17K-25.38%
Dec 31, 2018185.87K-225.80K-54.85%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo, Inc. 1.73B
Elite Pharmaceuticals 70.00M
Veradigm 588.02M
Tian'an Technology Group 1.78M
American Oncology Network 1.76B
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
Revenue Rankings

StageZero Life Sciences News

More News